Sandeep Kumar Jha

Sandeep Kumar Jha

Auto-generated profile, based on publicly available information

Sandeep Kumar Jha

Centre for Biomedical Engineering, Indian Institute of Technology Delhi, New Delhi 110016, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2025 in Sensors & Diagnostics
Verified
Journal Article
Open access
PDF file
SPShweta Panwar
Shweta Panwar
DKD. Syed Kasim
D. Syed Kasim
HSHarpreet Singh
Harpreet Singh
APAkanksha Priya
Akanksha Priya
KDK. K. Deepak
K. K. Deepak
SJSandeep Kumar Jha
Sandeep Kumar Jha
A portable bienzymatic biosensor enables rapid, non-invasive quantification of salivary glucose through colorimetric detection and derivative analysis for point-of-care diagnostics.

18 November 2025 in RSC Advances
Verified
Journal Article
Open access
PDF file
ASAmit Kumar Singh
Amit Kumar Singh
SPShweta Panwar
Shweta Panwar
SJSandeep Kumar Jha
Sandeep Kumar Jha
Non-communicable diseases such as diabetes and chronic kidney disease (CKD) are major global health concerns due to associated high morbidity rates. Conventional monitoring of these diseases typically involves invasive methods, which can be painful and inconvenient for patients. This study highlights the development of a non-invasive, handheld optical biosensor capable of multivariate analysis using saliva samples. The device used two distinct paper-fluidic strips designed with different enzyme–dye combinations to detect glucose and urea. The biosensor also used ambient temperature compensation to address the differential sensitivity of these sensors owing to variations caused by temperature-dependent enzyme kinetics, thereby enhancing the measurement accuracy. Biosensor characteristics with the glucose oxidase-based strip showed a sensitivity of 1.93 count per mg per dL, linearity range from 8 to 358 mg dL−1, limit of detection (LOD) of 8 mg dL−1, and response time of 7.35 s. The clinical validation shows good correlation between saliva glucose levels (SGLs) and blood glucose levels (BGLs). The urea biosensor strip shows a sensitivity of 1.51 count per mg per dL, LOD of 5 mg dL−1, linearity range from 5 to 90 mg dL−1, and response time of 3 s. The clinical validation for the CKD patient shows a significant correlation between blood urea levels and saliva urea levels. The results demonstrate that the device offers a rapid, reliable, and user-friendly alternative for point-of-care testing (POCT), potentially improving patient compliance and management of diabetes and CKD. Significance: The findings suggest that this technology could represent a significant advancement in non-invasive diagnostic tools and can be used as a POCT by chronic patients.